Literature DB >> 9835623

Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome.

E R Levin1, G F Rosen, D L Cassidenti, B Yee, D Meldrum, A Wisot, A Pedram.   

Abstract

Controlled ovarian hyperstimulation with gonadotropins is followed by Ovarian Hyperstimulation Syndrome (OHSS) in some women. An unidentified capillary permeability factor from the ovary has been implicated, and vascular endothelial cell growth/permeability factor (VEGF) is a candidate protein. Follicular fluids (FF) from 80 women who received hormonal induction for infertility were studied. FFs were grouped according to oocyte production, from group I (0-7 oocytes) through group IV (23-31 oocytes). Group IV was comprised of four women with the most severe symptoms of OHSS. Endothelial cell (EC) permeability induced by the individual FF was highly correlated to oocytes produced (r2 = 0.73, P < 0.001). Group IV FF stimulated a 63+/-4% greater permeability than FF from group I patients (P < 0. 01), reversed 98% by anti-VEGF antibody. Group IV fluids contained the VEGF165 isoform and significantly greater concentrations of VEGF as compared with group I (1,105+/-87 pg/ml vs. 353+/-28 pg/ml, P < 0. 05). Significant cytoskeletal rearrangement of F-actin into stress fibers and a destruction of ZO-1 tight junction protein alignment was caused by group IV FF, mediated in part by nitric oxide. These mechanisms, which lead to increased EC permeability, were reversed by the VEGF antibody. Our results indicate that VEGF is the FF factor responsible for increased vascular permeability, thereby contributing to the pathogenesis of OHSS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835623      PMCID: PMC509150          DOI: 10.1172/JCI4814

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  The role of prostaglandins in ovarian hyperstimulation syndrome.

Authors:  J G Schenker; W Z Polishuk
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1976       Impact factor: 2.435

2.  Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report.

Authors:  J S Krasnow; S L Berga; D S Guzick; A J Zeleznik; K T Yeo
Journal:  Fertil Steril       Date:  1996-03       Impact factor: 7.329

3.  Ovarian overstimulation syndrome.

Authors:  W Z Polishuk; J G Schenker
Journal:  Fertil Steril       Date:  1969 May-Jun       Impact factor: 7.329

4.  The spatial organization of corneal endothelial cytoskeletal proteins and their relationship to the apical junctional complex.

Authors:  P A Barry; W M Petroll; P M Andrews; H D Cavanagh; J V Jester
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-05       Impact factor: 4.799

Review 5.  Cell adhesion: the molecular basis of tissue architecture and morphogenesis.

Authors:  B M Gumbiner
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

6.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

7.  Effect of prolactin in an experimental model of the ovarian hyperstimulation syndrome.

Authors:  P Leung; B Ho Yuen; Y S Moon
Journal:  Am J Obstet Gynecol       Date:  1983-04-01       Impact factor: 8.661

8.  Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.

Authors:  J Neulen; Z Yan; S Raczek; K Weindel; C Keck; H A Weich; D Marmé; M Breckwoldt
Journal:  J Clin Endocrinol Metab       Date:  1995-06       Impact factor: 5.958

9.  ATP depletion: a novel method to study junctional properties in epithelial tissues. I. Rearrangement of the actin cytoskeleton.

Authors:  R Bacallao; A Garfinkel; S Monke; G Zampighi; L J Mandel
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

10.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.

Authors:  W G Roberts; G E Palade
Journal:  J Cell Sci       Date:  1995-06       Impact factor: 5.285

View more
  15 in total

Review 1.  Vascular growth factors in cerebral ischemia.

Authors:  S D Croll; S J Wiegand
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

Review 2.  Understanding ovarian hyperstimulation syndrome.

Authors:  Anne Delbaere; Guillaume Smits; Anne De Leener; Sabine Costagliola; Gilbert Vassart
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

3.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

4.  Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability.

Authors:  I Bekes; V Haunerdinger; R Sauter; I Holzheu; W Janni; A Wöckel; C Wulff
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-01       Impact factor: 2.915

5.  Granulocyte colony-stimulating factor in conjunction with vascular endothelial growth factor maintains primordial follicle numbers in transplanted mouse ovaries.

Authors:  Malgorzata E Skaznik-Wikiel; Rakesh K Sharma; Kaisa Selesniemi; Ho-Joon Lee; Jonathan L Tilly; Tommaso Falcone
Journal:  Fertil Steril       Date:  2011-01-26       Impact factor: 7.329

6.  Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization.

Authors:  Stephen R Lincoln; Michael S Opsahl; Keith L Blauer; Susan H Black; Joseph D Schulman
Journal:  J Assist Reprod Genet       Date:  2002-04       Impact factor: 3.412

7.  Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

Authors:  U Laufs; M Endres; N Stagliano; S Amin-Hanjani; D S Chui; S X Yang; T Simoncini; M Yamada; E Rabkin; P G Allen; P L Huang; M Böhm; F J Schoen; M A Moskowitz; J K Liao
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

8.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain.

Authors:  Z G Zhang; L Zhang; Q Jiang; R Zhang; K Davies; C Powers; N v Bruggen; M Chopp
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

9.  Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management.

Authors:  Michael M Alper; Laura P Smith; Eric Scott Sills
Journal:  J Exp Clin Assist Reprod       Date:  2009-06-10

10.  Severe ovarian hyperstimulation syndrome leading to ICU admission.

Authors:  R K Singh; Sanjay Singhal; Afzal Azim; A K Baronia
Journal:  Saudi J Anaesth       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.